Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
Pharma
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
The TROP2 ADC also awaits an FDA decision in EGFR-mutated lung cancer and a key readout in first-line non-small cell lung cancer in 2025.
Angus Liu
Jan 17, 2025 9:14pm
Anyone with lungs can get cancer, warns new campaign
Oct 23, 2024 12:46pm
American Lung Association aims to ‘BEAT’ cancer in new campaign
Jul 16, 2024 1:46pm
Janssen, Roche lead reputation rankings in common cancers
Jun 21, 2024 10:59am
Olympus mounts lung cancer education push with advocacy group
Mar 27, 2024 12:13pm
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am
